Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms

Reuters

2025/12/17

Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms

STAAR Surgical Company is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with Alcon Inc., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2592116799"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2592116799\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2592116799?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-17 23:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592116799","market":"nz","top_or_hot":-1,"title":"Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/STAA\">STAAR Surgical Company</a> is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with <a href=\"https://laohu8.com/S/ALC\">Alcon Inc</a>., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.</span></i>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBroadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-17 23:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/STAA\">STAAR Surgical Company</a> is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with <a href=\"https://laohu8.com/S/ALC\">Alcon Inc</a>., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.</span></i>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STAA","symbol_name":"STAAR Surgical Company","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL9n6DMK:1","article_id":"2592116799","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592116799","pubTimestamp":1765987094,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"STAAR Surgical Company is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with Alcon Inc., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STAA":"STAAR Surgical Company","BK4588":"碎股","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓"},"translate_title":"随着STAAR Surgical股东投票临近，布罗德伍德挑战爱尔康交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":0.9},"content_text":"Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n    \n\nSTAAR Surgical Company is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with Alcon Inc., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}